At the authors' practice of 11 000 patients, seven are registered with primary or secondary adrenal insufficiency. One such patient presented in Autumn 2013 (see Figures 1 and 2 demonstrating vitiligo of the face and hands). A 4-month delay in diagnosis occurred due to an extended period of primary care investigation for other (gastrointestinal) causes for the presenting symptoms. The diagnosis was made following an acute admission due to features of an Addisonian crisis including hypotension, vomiting, debilitating fatigue, and hyperkalaemia.
ClInICAl fEAturEs
A major problem with identifying people with AD is the non-specific nature of many of the presenting symptoms, at least in precrisis stages. Common symptoms, signs, and laboratory results are shown in Table 1 , and all can be associated with other, often more common, differential diagnoses.
A rapid appraisal of presentations of AD, conducted though MEDlINE ® via NHS Evidence, yielded many disparate presenting symptoms. In summary, diagnostic pitfalls to be aware of include a chronic presentation which may be misdiagnosed as one of a number of other problems, often based on a mental health diagnosis, for example anxiety or depression; precipitation into crisis through use of antidepressants (as sodiumdepleting) or through use of steroids for a comorbidity; evolution in pregnancy may be mistaken for chloasma and interpretation of serum cortisol measurement is harder in pregnancy, so if AD is suspected referral to endocrinology is essential; and erratic diabetes control, either recurrent hypoglycaemia or diabetic ketoacidosis.
InvEstIgAtIon
A high index of suspicion is needed as AD crises can be rapidly fatal. If suspected (features of persistent vomiting, muscle weakness, dehydration, hypotension, headache, extreme fatigue, and shock), 5 the patient should be admitted as a medical emergency. Otherwise, consider measuring urea and electrolytes (U&E) as sometimes, although by no means always, a low sodium and high potassium will be found, and a 9 am serum cortisol level. local reference ranges should be checked but generally, a serum cortisol result >500 nmol/l makes AD very unlikely, <100 nmol/l is definitely abnormally low 9 requiring rapid investigation. Results lying between these values are indeterminate and should prompt a short synacthen test. Additional relevant secondary care tests at the time of diagnosis include plasma adrenocorticotropic hormone and renin, and serum dehydroepiandrosterone sulfate; other hypothalamic-pituitary axis investigation may be warranted if secondary AD is suspected. 7 Further screening for other autoimmune conditions should be considered and are summarised in Box 1. ongoIng mAnAgEmEnt lifelong oral steroid supplementation is usually initiated and adjusted in secondary care by an endocrinologist and typically includes glucocorticoid (hydrocortisone) and mineralocorticoid (fludrocortisone) replacement. Under-replacement may be indicated by persisting symptoms or signs and over-replacement by hypertension, rEfErEnCEs thin skin, striae, easy bruising, glucose intolerance, hyperglycaemia, and electrolyte imbalance. Patients with AD should be informed that they are eligible for free prescriptions in the UK.
Individualised sick day rules need to be highlighted to patients, and flagged on primary care computer systems. Resources to assist with providing this information can be found at http://www.addisons.org.uk/. Self-administered injectable steroids may be provided in situations where rapid access to supportive treatment in a crisis is not guaranteed.
